Kwietniak Matthew R.'s Insider Trades & SAST Disclosures
Kwietniak Matthew R.'s most recent trade in Avid Bioservices Inc was a trade of 29,479 Common Stock, $0.001 par value done . Disclosure was reported to the exchange on Dec. 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kwietniak Matthew R..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avid Bioservices Inc | R. Matthew Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 29,479 | 64,186 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Kwietniak Matthew R. | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 15,972 | 94,307 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 15,972 | 78,335 | - | - | Performance Stock Units (FY 2025 Grant) | |
| Avid Bioservices Inc | R. Matthew Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 10,165 | 50,796 (0%) | 0% | 12.2 | 124,216 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew Kwietniak R. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Dec 2024 | 9,300 | 34,707 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew Kwietniak R. | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 6,782 | 117,061 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 6,782 | 110,279 | - | - | Performance Stock Units (FY 2024 Grant) | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 6,725 | 123,843 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 6,725 | 130,568 | - | - | Performance Stock Units (FY 2023 Grant) | |
| Avid Bioservices Inc | Matthew Kwietniak R. | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 4,494 | 65,812 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.22 per share. | 25 Dec 2024 | 3,225 | 60,961 (0%) | 0% | 12.2 | 39,410 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 1,908 | 70,306 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 1,893 | 72,214 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 25 Dec 2024 | 1,005 | 74,107 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 335 | 75,112 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Matthew Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 335 | 25,526 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.15 per share. | 11 Oct 2024 | 119 | 25,407 (0%) | 0% | 10.2 | 1,208 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2024 | 2,763 | 26,173 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Kwietniak R. Matthew | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Oct 2024 | 1,497 | 75,447 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Kwietniak R. Matthew | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.05 per share. | 09 Oct 2024 | 982 | 25,191 (0%) | 0% | 10.0 | 9,869 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Kwietniak Matthew R. | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Oct 2024 | 636 | 76,944 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Oct 2024 | 630 | 77,580 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2024 | 881 | 23,717 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2024 | 881 | 137,293 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.36 per share. | 12 Jul 2024 | 307 | 23,410 (0%) | 0% | 8.4 | 2,567 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 335 | 78,210 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 335 | 22,955 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 11 Jul 2024 | 119 | 22,836 (0%) | 0% | 8.1 | 958 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 95,833 | 170,565 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 47,916 | 79,812 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 1,267 | 23,064 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2024 | 636 | 79,176 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2024 | 631 | 78,545 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.54 per share. | 09 Jul 2024 | 444 | 22,620 (0%) | 0% | 7.5 | 3,348 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 30 Apr 2024 | 1,233 | 21,797 (0%) | 0% | 7.4 | 9,122 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 669 | 23,030 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 669 | 31,896 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,271 | 22,361 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,271 | 32,565 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,261 | 21,090 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 1,261 | 33,836 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 669 | 35,097 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Kwietniak R. Matthew | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 669 | 20,103 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Kwietniak Matthew R. | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.77 per share. | 11 Jan 2024 | 274 | 19,829 (0%) | 0% | 6.8 | 1,855 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Kwietniak Matthew R. | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,272 | 35,766 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,272 | 20,494 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,261 | 19,222 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | R. Kwietniak Matthew | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 1,261 | 37,038 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 09 Jan 2024 | 1,060 | 19,434 (0%) | 0% | 6.2 | 6,540 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 669 | 41,501 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2023 | 669 | 16,236 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.61 per share. | 11 Jul 2023 | 252 | 15,984 (0%) | 0% | 13.6 | 3,430 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 40,693 | 74,732 | - | - | Performance Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 20,346 | 43,431 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Jul 2023 | 1,261 | 42,170 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2023 | 1,261 | 16,044 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.77 per share. | 09 Jul 2023 | 477 | 15,567 (0%) | 0% | 13.8 | 6,569 | Common Stock, $0.001 par value |
| Avid Bioservices Inc | Matthew R. Kwietniak | Chief Commercial Officer | Other type of transaction at price $ 11.46 per share. | 30 Jun 2023 | 716 | 14,783 (0%) | 0% | 11.5 | 8,204 | Common Stock, $0.001 par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges